Physician profile
Jody L Amazon
NPI 1427038470
$3,673.33
in general payments reported to CMS, 2019-2025
18 companies · $1,117 in 2025
The $1,117 reported for 2025 was more than what 87% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $616 · 2022: $520 · 2023: $522 · 2024: $898 · 2025: $1,117.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,537.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,536.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $836.45 | 2021-2025 | |
| Otsuka America Pharmaceutical, INC. | $734.04 | 2023-2025 | Rexulti, Nuedexta, Abilify Asimtufii |
| Teva Pharmaceuticals USA, INC. | $403.63 | 2021-2025 | Uzedy, Austedo Xr, Austedo |
| Neurocrine Biosciences, INC. | $336.43 | 2023-2025 | Ingrezza |
| Eisai INC. | $169.31 | 2023-2025 | |
| Axsome Therapeutics, INC. | $148.17 | 2024-2025 | Auvelity |
| Acadia Pharmaceuticals INC | $132.47 | 2025 | Nuplazid |
| Lundbeck LLC | $130.09 | 2022-2025 | Rexulti, Brintellix |
| Alkermes, INC. | $129.21 | 2022-2023 | Lybalvi |
| Sanofi-Aventis U.S. LLC | $124.99 | 2022 | |
| Novo Nordisk INC | $119.76 | 2022 | |
| Corium, LLC | $116.38 | 2022-2023 | Adlarity |
| E.R. Squibb & Sons, L.L.C. | $91.45 | 2024-2025 | Cobenfy |
| Vanda Pharmaceuticals INC. | $78.67 | 2025 | Fanapt, Hetlioz |
| Takeda Pharmaceuticals U.S.A., INC. | $39.76 | 2022-2023 | Trintellix |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avanir Pharmaceuticals, INC. | $35.22 | 2021 | |
| Biogen, INC. | $28.45 | 2021 | |
| Lilly USA, LLC | $18.85 | 2025 | Kisunla |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jody Amazon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.